Further analysis showed that TRIM3 was elevated in TP53 wild type group in breast cancer cells, but failed to correlate with P53 target gene expression, nor prognosis in both P53 WT and mutant groups (Additional file 1: Fig. S1a–e). Here, TRIM3 is linked to breast carcinoma.